These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 28976864)

  • 41. Adjusting for Nonadherence or Stopping Treatments in Randomized Clinical Trials.
    Adler AI; Latimer NR
    JAMA; 2021 May; 325(20):2110-2111. PubMed ID: 34032845
    [No Abstract]   [Full Text] [Related]  

  • 42. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
    Matilde Sanchez M; Chen X
    Stat Med; 2006 Apr; 25(7):1169-81. PubMed ID: 16397861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Not Available].
    Messori A
    Recenti Prog Med; 2019 Nov; 110(11):533. PubMed ID: 31808438
    [No Abstract]   [Full Text] [Related]  

  • 44. Innovative and Pragmatic Research Designs Are Critical to Advance Nursing Science.
    Yates P
    Cancer Nurs; 2016; 39(3):251-2. PubMed ID: 27081921
    [No Abstract]   [Full Text] [Related]  

  • 45. The Primary Outcome Is Positive - Is That Good Enough?
    Pocock SJ; Stone GW
    N Engl J Med; 2016 Sep; 375(10):971-9. PubMed ID: 27602669
    [No Abstract]   [Full Text] [Related]  

  • 46. Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints.
    Patel A; Webster R
    PLoS Med; 2016 Mar; 13(3):e1001986. PubMed ID: 27022969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pragmatic Clinical Trials: Implementation Opportunity, or Just Another Fad?
    Delitto A
    Phys Ther; 2016 Feb; 96(2):137-8. PubMed ID: 26833116
    [No Abstract]   [Full Text] [Related]  

  • 48. What does digitalization hold for the creation of real-world evidence?
    Pisaniello HL; Dixon WG
    Rheumatology (Oxford); 2020 Jan; 59(1):39-45. PubMed ID: 31834405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beyond intention to treat: what is the right question?
    Shrier I; Steele RJ; Verhagen E; Herbert R; Riddell CA; Kaufman JS
    Clin Trials; 2014 Feb; 11(1):28-37. PubMed ID: 24096636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Addressing missing participant outcome data in dental clinical trials.
    Spineli LM; Fleming PS; Pandis N
    J Dent; 2015 Jun; 43(6):605-18. PubMed ID: 25837533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pragmatic Trials.
    Ford I; Norrie J
    N Engl J Med; 2016 Aug; 375(5):454-63. PubMed ID: 27518663
    [No Abstract]   [Full Text] [Related]  

  • 53. Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.
    Edwards T; Semple MG; De Weggheleire A; Claeys Y; De Crop M; Menten J; Ravinetto R; Temmerman S; Lynen L; Bah EI; Smith PG; van Griensven J;
    Clin Trials; 2016 Feb; 13(1):13-21. PubMed ID: 26768570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An investigation of clinical studies suggests those with multiple objectives should have at least 90% power for each endpoint.
    Borm GF; Houben RM; Welsing PM; Zielhuis GA
    J Clin Epidemiol; 2006 Jan; 59(1):1-6. PubMed ID: 16360554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pragmatic trials are important to medical research].
    Bjerre E; Brasso K; Midtgaard J
    Ugeskr Laeger; 2015 Jul; 177(31):. PubMed ID: 26238009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dropout rates for intent-to-treat and per protocol analyses.
    Stewart WC; Jackson AL; Jenkins JN
    Am J Ophthalmol; 2004 Apr; 137(4):639-45. PubMed ID: 15059702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The implications of non-compliance: Randomised controlled trials: the intention-to-treat principle.
    Platt AC; Turner EL
    BJOG; 2019 Oct; 126(11):1337. PubMed ID: 31222882
    [No Abstract]   [Full Text] [Related]  

  • 58. Analyzing phase III studies in hospice/palliative care. a solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis.
    Currow DC; Plummer JL; Kutner JS; Samsa GP; Abernethy AP
    J Pain Symptom Manage; 2012 Oct; 44(4):595-603. PubMed ID: 22819439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Challenges of Non-Intention-to-Treat Analyses.
    DeMets DL; Cook T
    JAMA; 2019 Jan; 321(2):145-146. PubMed ID: 30556836
    [No Abstract]   [Full Text] [Related]  

  • 60. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.